Advances in antibiotic heteroresistance in Acinetobacter baumannii

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Acinetobacter baumannii is a significant cause of hospital-acquired infections.
• Increasing multidrug and pandrug resistance in A. baumannii complicates treatment.
• Heteroresistance, the presence of low-frequency resistant subpopulations, is a growing concern.

Purpose of the Study:

• To systematically review the definition, detection, mechanisms, and therapeutic strategies for A. baumannii heteroresistance.
• To highlight the clinical challenge posed by overlooked heteroresistant subpopulations.
• To provide a reference for rational antimicrobial use and novel antibacterial strategies.

Main Methods:

• Review of current literature on A. baumannii heteroresistance.
• Analysis of molecular mechanisms including genetic mutations, gene amplification, efflux pumps, and membrane modifications.
• Discussion of emerging technologies for heteroresistance detection (e.g., single-cell analysis, microfluidics).

Main Results:

• Heteroresistance in A. baumannii arises from diverse molecular mechanisms.
• Mechanisms vary by antibiotic class, with multiple pathways potentially coexisting.
• Monotherapy may fail and promote resistant subpopulations; combination therapy is a potential strategy.

Conclusions:

• Accurate detection of A. baumannii heteroresistance is often hindered by a lack of standardized methods.
• Combination therapy shows promise but requires further clinical validation.
• Advancements in technology are key to precise and rapid heteroresistance detection and management.